U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; Eunice Kennedy Shriver National Institute of Child Health and Human Development(NICHD); National Institute of Allergy and Infectious Diseases (NIAID) - Friday, December 18, 2009
CONTACTS: Robert Bock or Marianne Glass Miller, NICHD, 301-496-5133, e-mail:bockr@mail.nih.gov | Laura Sivitz, NIAID, 301-402-1663, e-mail:sivitzl@niaid.nih.gov
The death rates of children with HIV have decreased ninefold since doctors started prescribing cocktails of antiretroviral drugs in the mid-1990s, concludes a large-scale study of the long-term outcomes of children and adolescents with HIV in the United States . In spite of this improvement, however, young people with
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News;National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, December 10, 2009
CONTACT: NIAID Office of Communications, 301-402-166, e-mail:niaidnews@niaid.nih.gov
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
For HIV-infected individuals starting antiretroviral therapy, it has been unclear which of two commonly used drug combinations is safer and more effective: abacavir plus lamivudine or tenofovir plus emtricitabine. Now, the first published results of a study known as A5202 indicate that the
WHAT: New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Sc
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - October 15, 2009
This seventh annual National Latino AIDS Awareness Day marks an occasion for all of us to consider the impact HIV has had on the Latino community and what we can do to prevent future infections among the largest and fastest growing ethnic minority group in the United States . Since the HIV/AIDS epidemic began, more tha
U.S. Department of Health and Human Services; NATIONAL INSTITUTES OF HEALTH NIH News; National Institute of Allergy and Infectious Diseases (NIAID) http://www.niaid.nih.gov/ - September 25, 2009
CONTACT: Laura Sivitz, 301-402-1663, e-mail: sivitzl@niaid.nih.gov
On Sept. 27, the second annual National Gay Men s HIV/AIDS Awareness Day, we pause to mourn the hundreds of thousands of gay and bisexual men who have died with AIDS, and we strengthen our resolve to end this terrible scourge. In the early years of the HIV/AIDS epidemic in the United States , the virus wreaked most
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, September 24, 2009
MEDIA CONTACT: Kathy Stover, 301-402-1663, e-mail: stoverk@niaid.nih.gov
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand . Following a final analysis of the trial data, the Surgeon General of the U.S. Army
The Centers for Disease Control and Prevention estimates that approximately 25 percent of HIV-infected people in the United States are also infected with the hepatitis C virus (HCV). HCV infection is a major cause of liver damage and progresses more rapidly in HIV-infected people. Researchers at the National Institute
HIV/AIDS began its deadly course in the United States mostly as a disease of young men, but today the epidemic touches people of all ages, including adults aged 50 and older. On September 18, the first annual National HIV/AIDS and Aging Awareness Day, we pause to recognize the importance of preventing HIV infection in
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, September 17, 2009
CONTACT: Laura Sivitz, 301-402-1663, e-mail:sivitzl@niaid.nih.gov
HIV/AIDS began its deadly course in the United States mostly as a disease of young men, but today the epidemic touches people of all ages, including adults aged 50 and older. On September 18, the first National HIV/AIDS and Aging Awareness Day, we pause to recognize the importance of preventing HIV infection in this ag
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News, National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, September 16, 2009
MEDIA CONTACT: Laura Sivitz, 301-402-1663, e-mail: sivitzl@niaid.nih.gov
A new, large-scale clinical trial is examining whether antiretroviral medications normally used to treat HIV infection can also prevent HIV infection in women when applied as a vaginal gel or taken as oral tablets once daily. The study, called Vaginal and Oral Interventions to Control the Epidemic (VOICE) or MTN-003, w
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News, National Institute of Allergy and Infectious Diseases (NIAID) - Sunday, August 2, 2009
MEDIA CONTACT: Laura Sivitz, 301-402-1663, e-mail: sivitzl@niaid.nih.gov
New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes , increases the risk for HIV infection even after successful treatment heals the genital skin sores and breaks that often result from HSV-2. Scientists have uncovered details of an immune-cell environment conducive
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Tuesday, June 23, 2009
CONTACT: Laura Sivitz, 301-402-1663, e-mail: sivitzl@niaid.nih.gov
The importance of National HIV Testing Day becomes clear when one recognizes that an estimated one-fifth of all Americans infected with HIV do not know they are infected.[1] Among Americans who have been tested for the virus, more than one-third of those who learned they are infected became aware of their status less t
U.S. Department of Health and Human Services; National Institutes of Health, NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Sunday, June 14, 2009
WHAT: Most vaccines that protect against viruses generate infection-fighting proteins called antibodies that either block infection or help eliminate the virus before it can cause disease. Attempts to create a vaccine that induces antibodies that prevent HIV infection or disease, however, have so far been unsuccessful.
U.S. Department of Health and Human Services; National Institutes of Health, NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Tuesday, June 9, 2009
CONTACT: Laura Sivitz, 301-402-1663, e-mail:sivitzl@niaid.nih.gov
Could a global program of universal, voluntary, annual HIV testing and immediate treatment for those who test positive effectively extinguish the HIV pandemic? Is such a program feasible? In the June 10 issue of the Journal of the American Medical Association , top HIV/AIDS research leaders at the National Institute of
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Monday, June 8, 2009
CONTACT: Laura Sivitz, 301-402-1663, e-mail:sivitzl@niaid.nih.gov
A clinical trial has demonstrated that HIV-infected adults in a resource-limited setting are more likely to survive if they start antiretroviral therapy (ART) before their immune systems are severely compromised. On May 28, 2009, an independent data and safety monitoring board (DSMB) met to conduct an interim review of
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Monday, May 18, 2009
Contact: NIAID Office of Communications, 301-402-1663, e-mail: niaidnews@niaid.nih.gov
On the fifth annual National Asian & Pacific Islander HIV/AIDS Awareness Day, we focus our attention on concrete steps to reduce the impact of HIV on Asians and Pacific Islanders in the United States . Asian and Pacific Islander communities in this country are incredibly diverse, comprising more than 40 different e
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Friday, May 15, 2009
Contact: NIAID Office of Communications, 301-402-1663, e-mail:niaidnews@niaid.nih.gov
On this 12th annual HIV Vaccine Awareness Day, we reaffirm our commitment to the research needed to develop a safe and effective HIV vaccine. People continue to become infected with HIV at an alarming rate. An estimated 2.7 million new HIV infections occurred worldwide in 2007 alone. Here in the United States
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) National Cancer Institute (NCI) - Wednesday, May 6, 2009
CONTACTS: Laura Sivitz, 301-402-1663, e-mail:sivitzl@niaid.nih.gov | NCI Office of Media Relations, 301-496-6641, e-mail: ncipressofficers@mail.nih.gov
The longest U.S. study of people with HIV/AIDS will be honored at a 25th anniversary commemoration on May 12, 2009, at the Carnegie Institution for Science in Washington, D.C. The Multicenter AIDS Cohort Study (MACS) has significantly contributed to the scientific understanding of HIV, AIDS and the effects of antiretro
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; John E. Fogarty International Center for Advanced Study in the Health Sciences (FIC) - Thursday, April 16, 2009
Contact: Ira R. Allen, 301-496-8734, e-mail: alleni@mail.nih.gov
The Fogarty International Center of the National Institutes of Health today announced it will award $11.75 million over five years in grants to institutions to strengthen the fight against HIV/AIDS and tuberculosis in Haiti , Uganda and China and establish a new program in
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, April 16, 2009
Contacts: Laura Sivitz, 301-402-1663, e-mail:niaidnews@niaid.nih.gov | Bill Schmalfeldt, NIH Clinical Center Communications, 301-496-2563, e-mail:schmalfeldtb@cc.nih.gov | Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention News Media Line, 404-639-8895, e-mail:NCHHSTPMediaTeam@cdc.gov
The first complete update in five years of the U.S. guidelines for preventing and treating HIV-associated opportunistic infections has been released by the National Institutes of Health and the Centers for Disease Control and Prevention in cooperation with the HIV Medicine Association of the Infectious Diseases Society
U.S. Department of Health and Human Services; National Institutes of Health NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, March 25, 2009
Heterosexual men who undergo medical circumcision can significantly reduce their risk of acquiring two common sexually transmitted infections-herpes simplex virus type 2 (HSV-2), the cause of genital herpes , and human papillomavirus (HPV), which can cause cancer and genital warts, according to a report in the March 26
U.S. Department of Health and Human Services; National Institutes Of Health NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Tuesday, March 24, 2009
CONTACT: NIAID Office of Communications, 301-402-1663, e-mail: niaidnews@niaid.nih.gov
This year, as we commemorate World TB Day, we renew our resolve to stop tuberculosis. Although mindful of the substantial challenges that confront us in the ultimate goal of eliminating tuberculosis, we are encouraged by recent progress in fighting this lethal infection. The theme of this year s World TB Day, I Am Stop
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - March 13, 2009
Contact: Laura Sivitz, 301-402-1663, e-mail:sivitzl@niaid.nih.gov
HIV/AIDS has left no segment of American society untouched. On the third annual National Native HIV/AIDS Awareness Day, we highlight the impact of this scourge on American Indians, Alaska Natives and Native Hawaiians, and we intensify our commitment to fight the HIV/AIDS epidemic in these multifaceted communities. Lack
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, March 4, 2009
Contact: Laura Sivitz, 301-402-1663, e-mail:sivitzl@niaid.nih.gov
The fourth annual National Women and Girls HIV/AIDS Awareness Day reminds us of the special risks that HIV/AIDS poses for women and girls. In response to the unique issues they face, we renew our resolve to help women and girls protect themselves from the virus and the disease. Women and girls represent more than a qua
U.S. Department of Health and Human Services; National Institutes of Health NIH News; National Institute of Allergy and Infectious Diseases (NIAID) http://www.niaid.nih.gov - Tuesday, February 10, 2009
CONTACT: Laura Sivitz, 301-402-1663, e-mail: sivitzl@niaid.nih.gov
Providing a synthetic form of the immune system protein interleukin-2 ( IL-2 ) to HIV-infected individuals already taking combination antiretroviral therapy boosts their numbers of CD4+ T cells, the key white blood cells destroyed by HIV, but fails to reduce their risk of HIV-associated opportunistic diseases or death
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Monday, February 9, 2009
An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States . Findings of the recently concluded study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH,
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Wednesday, February 4, 2009
CONTACT: NIAID Office of Communications, 301-402-1663, e-mail: niaidnews@niaid.nih.gov
The scourge of HIV/AIDS, which continues to affect the African-American community disproportionately, highlights the importance of a comprehensive strategy to address the U.S. epidemic.
National Institute of Allergy and Infectious Diseases; National Institutes of Health - January 23, 2009
Martin Delaney, the founder and longtime director of the HIV advocacy/education organization Project Inform, died of liver cancer at his home near San Francisco on January 23, 2009. Mr. Delaney was 63. Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National
NIH NEWS; National Institute of Allergy and Infectious Diseases; National Institutes of Health - Monday, January 19, 2009
Media Contact: Greg Folkers, (240) 505-7684, gfolkers@nih.gov
Martin Delaney, the founder and longtime director of the HIV advocacy/education organization Project Inform, has been presented with the National Institute of Allergy and Infectious Diseases (NIAID) Director s Special Recognition Award for his many contributions to the fight against HIV/AIDS. Mr. Delaney in 1985 founde
This information is designed to support, not replace, the relationship that exists between you and your doctor.